Effect of eugenol on cell surface hydrophobicity, adhesion, and biofilm of candida tropicalis and candida dubliniensis isolated from oral cavity of HIV-infected patients

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  De Paula, Suelen Balero ^a   Bartelli, Thais Fernanda ^a   Di Raimo, Vanessa ^a   Santos, Jussevania Pereira ^a   Morey, Alexandre Tadachi ^a   Bosini, Marina Andrea ^a   Nakamura, Celso Vataru ^b   Yamauchi, Lucy Megumi ^a   Yamada Ogatta, Sueli Fumie ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EUGENOL; FLUCONAZOLE; POLY(METHYL METHACRYLATE); POLYSTYRENE;

ADHERENT CELL; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BIOFILM; CANDIDA DUBLINIENSIS; CANDIDA TROPICALIS; CELL ADHESION; CELL SURFACE; CONTROLLED STUDY; DENTURE; FUNGICIDAL ACTIVITY; FUNGUS GROWTH; FUNGUS ISOLATION; HEP 2 CELL; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN TISSUE; HYDROPHOBICITY; MINIMUM INHIBITORY CONCENTRATION; MOUTH CAVITY; NONHUMAN; PLANKTON; SCANNING ELECTRON MICROSCOPY; YEAST CELL;

EID: 84899464252     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/505204     Document Type: Article

References (37)

1. Kumamoto C. A., Vinces M. D., Alternative Candida albicans lifestyles: growth on surfaces. Annual Review of Microbiology 2005 59 113 133 2-s2.0-27144503650 10.1146/annurev.micro.59.030804.121034
2. Pfaller M. A., Diekema D. J., Epidemiology of invasive candidiasis: a persistent public health problem. Clinical Microbiology Reviews 2007 20 1 133 163 2-s2.0-33846466508 10.1128/CMR.00029-06
3. Rautemaa R., Ramage G., Oral candidosis Clinical challenges of a biofilm disease. Critical Reviews in Microbiology 2011 37 4 328 336 2-s2.0-80053623392 10.3109/1040841X.2011.585606
4. Donlan R. M., Costerton J. W., Biofilms: survival mechanisms of clinically relevant microorganisms. Clinical Microbiology Reviews 2002 15 2 167 193 2-s2.0-0036228505 10.1128/CMR.15.2.167-193.2002
5. Ramage G., Walle K. V., Wickes B. L., López-Ribot J. L., Biofilm formation by Candida dubliniensis. Journal of Clinical Microbiology 2001 39 9 3234 3240 2-s2.0-0034837301 10.1128/JCM.39.9.3234-3240.2001
6. Bizerra F. C., Nakamura C. V., De Poersch C., Estivalet Svidzinski T. I., Borsato Quesada R. M., Goldenberg S., Krieger M. A., Yamada-Ogatta S. F., Characteristics of biofilm formation by Candida tropicalis and antifungal resistance. FEMS Yeast Research 2008 8 3 442 450 2-s2.0-42649131373 10.1111/j.1567-1364.2007.00347.x
7. Melo A. S., Bizerra F. C., Freymüller E., Arthington-Skaggs B. A., Colombo A. L., Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex. Medical Mycology 2011 49 3 253 262 2-s2.0-79952664196 10.3109/13693786.2010.530032
8. Katragkou A., Kruhlak M. J., Simitsopoulou M., Chatzimoschou A., Taparkou A., Cotten C. J., Paliogianni F., Diza-Mataftsi E., Tsantali C., Walsh T. J., Roilides E., Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents. Journal of Infectious Diseases 2010 201 12 1941 1949 2-s2.0-77952559259 10.1086/652783
9. Cao Y., Dai B., Wang Y., Huang S., Xu Y., Cao Y., Gao P., Zhu Z., Jiang Y., In Vitro activity of baicalein against Candida albicans biofilms. International Journal of Antimicrobial Agents 2008 32 1 73 77 2-s2.0-44949147073 10.1016/j.ijantimicag.2008.01.026
10. He M., Du M., Fan M., Bian Z., In Vitro activity of eugenol against Candida albicans biofilms. Mycopathologia 2007 163 3 137 143 2-s2.0-33947499532 10.1007/s11046-007-0097-2
11. Khan M. S., Ahmad I., Antibiofilm activity of certain phytocompounds and their synergy with fluconazole against Candida albicans biofilms. Journal of Antimicrobial Chemotherapy 2012 67 3 618 621 2-s2.0-84856959274 10.1093/jac/dkr512 dkr512
12. De Vincenzi M., Silano M., Stacchini P., Scazzocchio B., Constituents of aromatic plants: I. Methyleugenol. Fitoterapia 2000 71 2 216 221 2-s2.0-0034177688 10.1016/S0367-326X(99)00150-1
13. Nakamura C. V., Ishida K., Faccin L. C., Filho B. P. D., Cortez D. A. G., Rozental S., De Souza W., Ueda-Nakamura T., In Vitro activity of essential oil from Ocimum gratissimum L. against four Candida species. Research in Microbiology 2004 155 7 579 586 2-s2.0-4143124737 10.1016/j.resmic.2004.04.004
14. Chami N., Bennis S., Chami F., Aboussekhra A., Remmal A., Study of anticandidal activity of carvacrol and eugenol in vitro and in vivo. Oral Microbiology and Immunology 2005 20 2 106 111 2-s2.0-14944365219 10.1111/j.1399-302X.2004.00202.x
15. Pinto E., Vale-Silva L., Cavaleiro C., Salgueiro L., Antifungal activity of the clove essential oil from Syzygium aromaticum on Candida, Aspergillus and dermatophyte species. Journal of Medical Microbiology 2009 58 11 1454 1462 2-s2.0-70350516484 10.1099/jmm.0.010538-0
16. Ahmad A., Khan A., Manzoor N., Khan L. A., Evolution of ergosterol biosynthesis inhibitors as fungicidal against Candida. Microbial Pathogenesis 2010 48 1 35 41 2-s2.0-72149084112 10.1016/j.micpath.2009.10.001
17. Marcos-Arias C., Eraso E., Madariaga L., Quindós G., In Vitro activities of natural products against oral Candida isolates from denture wearers. BMC Complementary and Alternative Medicine 2011 11 119 2-s2.0-82055171731 10.1186/1472-6882-11-119
18. Khan M. S., Malik A., Ahmad I., Anti-candidal activity of essential oils alone and in combination with amphotericin B or fluconazole against multi-drug resistant isolates of Candida albicans. Medical Mycology 2012 50 1 33 42 2-s2.0-83755164273 10.3109/13693786.2011.582890
19. Nucci M., Queiroz-Telles F., Tobón A. M., Restrepo A., Colombo A. L., Epidemiology of opportunistic fungal infections in latin America. Clinical Infectious Diseases 2010 51 5 561 570 2-s2.0-77955828444 10.1086/655683
20. Pfaller M. A., Messer S. A., Moet G. J., Jones R. N., Castanheira M., Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009). International Journal of Antimicrobial Agents 2011 38 1 65 69 2-s2.0-79958066469 10.1016/j.ijantimicag.2011.02.016
21. Sullivan D. J., Westerneng T. J., Haynes K. A., Bennett D. E., Coleman D. C., Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 1995 141 7 1507 1521 2-s2.0-0029100965
22. Kurtzman C. P., Fell J. W., The Yeasts. A Taxonomic Study 1998 4th New York, NY, USA Elsevier
23. Donnelly S. M., Sullivan D. J., Shanley D. B., Coleman D. C., Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences. Microbiology 1999 145 8 1871 1882 2-s2.0-0032819806
24. Ahmad S., Khan Z., Mustafa A. S., Khan Z. U., Seminested PCR for diagnosis of candidemia: comparison with culture, antigen detection, and biochemical methods for species identification. Journal of Clinical Microbiology 2002 40 7 2483 2489 2-s2.0-0036308984 10.1128/JCM.40.7.2483-2489.2002
25. Clinical and Laboratory Standards Institute (CLSI), Clinical and Laboratory Standards Institute: reference method for broth dilution antifungal susceptibility testing of yeasts. 3rd ed. Document 2008 M27-A3 Wayne, Pa, USA Clinical and Laboratory Standards Institute
26. Anil S., Ellepola A. N. B., Samaranayake L. P., The impact of chlorhexidine gluconate on the relative cell surface hydrophobicity of oral Candida albicans. Oral Diseases 2001 7 2 119 122 2-s2.0-0035052657 10.1034/j.1601-0825.2001.0070210.x
27. Pauli A., Kubeczka K., Antimicrobial properties of volatile phenylpropanes. Natural Product Communications 2010 5 9 1387 1394 2-s2.0-77956658155
28. Pramod K., Ansari S. H., Ali J., Eugenol: a natural compound with versatile pharmacological actions. Natural Product Communications 2010 5 12 1999 2006 2-s2.0-78751519802
29. Khan A., Ahmad A., Akhtar F., Yousuf S., Xess I., Khan L. A., Manzoor N., Induction of oxidative stress as a possible mechanism of the antifungal action of three phenylpropanoids. FEMS Yeast Research 2011 11 1 114 122 2-s2.0-78651415146 10.1111/j.1567-1364.2010.00697.x
30. Khan M. S., Ahmad I., Cameotra S. S., Phenyl aldehyde and propanoids exert multiple sites of action towards cell membrane and cell wall targeting ergosterol in Candida albicans. AMB Express 2013 3 1 54 10.1186/2191-0855-3-54
31. Ahmad A., Khan A., Yousuf S., Khan L. A., Manzoor N., Proton translocating ATPase mediated fungicidal activity of eugenol and thymol. Fitoterapia 2010 81 8 1157 1162 2-s2.0-78549265110 10.1016/j.fitote.2010.07.020
32. Klotz S. A., Drutz D. J., Zajic J. E., Factors governing adherence of Candida species to plastic surfaces. Infection and Immunity 1985 50 1 97 101 2-s2.0-0021965247
33. Hazen K. C., Brawner D. L., Riesselman M. H., Jutila M. A., Cutler J. E., Differential adherence of hydrophobic and hydrophilic Candida albicans yeast cells to mouse tissues. Infection and Immunity 1991 59 3 907 912 2-s2.0-0026058058
34. Borghi E., Sciota R., Biassoni C., Cirasola D., Cappelletti L., Vizzini L., Boracchi P., Morace G., Cell surface hydrophobicity: a predictor of biofilm production in Candida isolates? Journal of Medical Microbiology 2011 60 5 689 690 2-s2.0-79955647982 10.1099/jmm.0.026898-0
35. Imbert C., Rodier M.-H., Daniault G., Jacquemin J.-L., Influence of sub-inhibitory concentrations of conventional antifungals on metabolism of Candida albicans and on its adherence to polystyrene and extracellular matrix proteins. Medical Mycology 2002 40 2 123 129 2-s2.0-0036247443
36. Ellepola A. N., Samaranayake L. P., The postantifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesion. Oral Diseases 1998 4 4 260 267 2-s2.0-0032422584
37. Chami F., Chami N., Bennis S., Trouillas J., Remmal A., Evaluation of carvacrol and eugenol as prophylaxis and treatment of vaginal candidiasis in an immunosuppressed rat model. Journal of Antimicrobial Chemotherapy 2004 54 5 909 914 2-s2.0-8844239121 10.1093/jac/dkh436